glucarpidase: Clinical Trials

7 trials of glucarpidase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated, 2 completed, 1 suspended. 7 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Terminated 4, Completed 2, Suspended 1
Phase 12Completed 1, Terminated 1

Follow glucarpidase: new trials by email Literature Review of glucarpidase trials Research Report on glucarpidase

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS
Glucarpidase 1000 UNT [Voraxaze] - Diffuse Large B-Cell Lymphoma, Drug Toxicity
Phase 2TerminatedFundacion CRIS de Investigación para Vencer el Cáncer32021-07-192024-05-13
HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma
Glucarpidase - Lymphoma
Phase 2SuspendedFox Chase Cancer Center32021-04-162024-03-22
High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma
glucarpidase, leucovorin - Osteosarcoma
Phase 2TerminatedBTG International Inc.72008-10-012014-09-15
Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
glucarpidase, leucovorin calcium, methotrexate - Chemotherapeutic Agent Toxicity, Lymphoma
Phase 1 / Phase 2CompletedUniversity College, London42008-07-012014-01-27
Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?
Glucarpidase, Methotrexate, Folinic Acid - Osteosarcoma, Spindle Cell Sarcoma of Bone
Phase 2TerminatedUniversity College, London342007-07-012015-06-04
Voraxaze for Delayed Methotrexate Clearance
Voraxaze (Glucarpidase), Placebo - Hematologic Malignancy, Solid Tumor
Phase 1 / Phase 2TerminatedM.D. Anderson Cancer Center32007-01-012012-12-06
Study of Glucarpidase (CPG2) for the Management of Patients With Delayed Methotrexate Clearance
glucarpidase (50 Units/kg) - Neoplasms
Phase 2CompletedBTG International Inc.2000-01-012014-09-11

Conditions studied

Lymphoma (2)  ·  Lymphoma, Large B-Cell, Diffuse (2)  ·  Mucositis (2)  ·  Osteosarcoma (2)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Hematologic Neoplasms (1)  ·  Neoplasms (1)  ·  Neurotoxicity Syndromes (1)  ·  Renal Insufficiency (1)

Sponsors

BTG International Inc. (2)  ·  University College, London (2)  ·  Fox Chase Cancer Center (1)  ·  Fundacion CRIS de Investigación para Vencer el Cáncer (1)  ·  M.D. Anderson Cancer Center (1)

Countries

United Kingdom (2)  ·  United States (2)  ·  Germany (1)  ·  Spain (1)

Top investigators

Adolfo De la Fuente, PD (1)  ·  Jeremy Whelan, Professor (1)  ·  Pete Anderson, MD, PhD (1)  ·  Roderick Johnson, MD (1)  ·  Saroj Vadhan-Raj, MD (1)  ·  Thiel Eckhard, Prof. Dr.med. (1)